For research use only. Not for therapeutic Use.
PI-3065 (Cat.No:I005659) is a novel potent and selective PI3K p110δ inhibitor with IC50 of 15 nM; exhibits > 100 fold selectivity against p110α, p110β, p110γ, DNA-PK and mTOR.
Catalog Number | I005659 |
CAS Number | 955977-50-1 |
Synonyms | PI3065;PI 3065; |
Molecular Formula | C27H31FN6OS |
Purity | ≥95% |
Target | PI3K |
Solubility | 10 mM in DMSO |
Storage | Store at -20°C |
IC50 | 15 nM |
IUPAC Name | 4-[6-[[4-(cyclopropylmethyl)piperazin-1-yl]methyl]-2-(5-fluoro-1H-indol-4-yl)thieno[3,2-d]pyrimidin-4-yl]morpholine |
InChI | InChI=1S/C27H31FN6OS/c28-21-3-4-22-20(5-6-29-22)24(21)26-30-23-15-19(17-33-9-7-32(8-10-33)16-18-1-2-18)36-25(23)27(31-26)34-11-13-35-14-12-34/h3-6,15,18,29H,1-2,7-14,16-17H2 |
InChIKey | YDNOHCOYQVZOMC-UHFFFAOYSA-N |
SMILES | C1CC1CN2CCN(CC2)CC3=CC4=C(S3)C(=NC(=N4)C5=C(C=CC6=C5C=CN6)F)N7CCOCC7 |
Reference | [1]. Ali K, et al. Inactivation of PI(3)K p110δ breaks regulatory T-cell-mediated immune tolerance to cancer. Nature. 2014 Jun 19;509(7505):407-11. |